Technology News and Research

RSS

Beckman Coulter Life Sciences and HSE•AG partner to revolutionize nucleic acid quantification and purification through liquid handling

Beckman Coulter Life Sciences, a Danaher company and global leader in laboratory automation and innovation, is redefining nucleic acid quantification through a strategic collaboration with Hombrechtikon Systems Engineering•AG (HSE•AG), a Swiss provider of customized automation and engineering solutions for the life sciences and diagnostics sectors.

From Beckman Coulter Life Sciences 4 Sep 2025

Study links high intake of artificial sweeteners to faster cognitive decline

Some sugar substitutes may come with unexpected consequences for long-term brain health, according to a study published in the September 3, 2025, issue of Neurology, the medical journal of the American Academy of Neurology.

3 Sep 2025

Penn State team develops wearable sensor to track health through minimal sweat

Available on-demand, in abundance and containing multiple biomarkers, sweat is an increasingly appealing medium for monitoring health, according to researchers at Penn State.

3 Sep 2025

Sugar-coated nanoparticles offer new hope for treating triple-negative breast cancer

Triple-negative breast cancer is particularly aggressive and difficult to treat; but recent research may offer a new way to target the often-deadly disease.

3 Sep 2025

Home-based hypertension care improves blood pressure control in rural South Africa

Home-based hypertension care led to reductions in systolic blood pressure and improvements in hypertension control in South Africa, according to late-breaking research presented in a Hot Line session today at ESC Congress 2025 and simultaneously published in the New England Journal of Medicine.

3 Sep 2025

Novel ablation approach improves outcomes in patients with persistent atrial fibrillation

Adding digital twin-guided ablation to a standard ablation technique improved outcomes in patients with persistent atrial fibrillation (AF), according to late-breaking research presented in a Hot Line session today at ESC Congress 2025.

3 Sep 2025

Changes at NIH give political appointees greater power to fund or block research

The Trump administration has given notice that political appointees, rather than scientists, will ultimately decide who gets grant money from the world’s largest biomedical research funder — the federal government's National Institutes of Health.

3 Sep 2025

At CDC, worries mount that agency has taken anti-science turn

Public health and access to lifesaving vaccines are on the line in a high-stakes leadership battle at the Centers for Disease Control and Prevention.

3 Sep 2025

Roasted Arabica coffee hides powerful antidiabetic molecules

Three novel coffee diterpene esters, caffaldehydes A, B, and C, were discovered in Arabica beans, showcasing significant alpha-glucosidase inhibitory activity.

3 Sep 2025

Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management

Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered imaging and clinical data curation platform, today announced the appointment of Craig Rhodes as Head of Partnerships to lead strategic engagements with pharmaceutical organizations, in line with Qureight’s revenue growth targets.

From Qureight 3 Sep 2025

TRIMTECH Therapeutics establishes Scientific Advisory Board

TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the formation of its Scientific Advisory Board (SAB).

From TRIMTECH Therapeutics 3 Sep 2025

Household WiFi devices show potential for nonintrusive health monitoring

Heart rate is one of the most basic and important indicators of health, providing a snapshot into a person's physical activity, stress and anxiety, hydration level, and more.

2 Sep 2025

Urine test identifies three biomarkers for accurate prostate cancer detection

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers present in urine, funded in part by the National Institutes of Health.

2 Sep 2025

Single-cell transcriptomics reveals new players in liver regeneration

The liver is remarkable for its ability to regenerate after injury, yet when this process fails, acute liver failure (ALF) carries devastating outcomes.

2 Sep 2025

Researchers reveal how diseases interact at the genetic level

2 Sep 2025

Dormant tumor cells targeted to reduce breast cancer relapse

A first-of-its-kind, federally funded clinical trial has shown it's possible to identify breast cancer survivors who are at higher risk of their cancer coming back due to the presence of dormant cancer cells and to effectively treat these cells with repurposed, existing drugs.

2 Sep 2025

Nanostructures boost CRISPR delivery for genetic medicine

With the power to rewrite the genetic code underlying countless diseases, CRISPR holds immense promise to revolutionize medicine. But until scientists can deliver its gene-editing machinery safely and efficiently into relevant cells and tissues, that promise will remain out of reach.

2 Sep 2025

Social Security praises its new chatbot. Ex-officials say it was tested but shelved under Biden.

John McGing couldn't reach a human. That might be business-as-usual in this economy, but it wasn't business; he had called the Social Security Administration, where the questions often aren't generic and the callers tend to be older, disabled, or otherwise vulnerable Americans.

2 Sep 2025

Aptamer signs therapeutic development agreement with Invizius

Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce that it has signed a new therapeutic development agreement with Invizius, a clinical-stage biotechnology company focused on second-generation complement system therapies for inflammatory, fibrotic, and autoimmune diseases.

From Aptamer Group 2 Sep 2025

Compounds show significant inhibitory effects on α-glucosidase

Three of the compounds demonstrated significant inhibitory effects on α-glucosidase, a key enzyme in carbohydrate digestion. The findings could pave the way for new functional food ingredients targeting type 2 diabetes.

2 Sep 2025

Technology News and Research

Beckman Coulter Life Sciences and HSE•AG partner to revolutionize nucleic acid quantification and purification through liquid handling

Study links high intake of artificial sweeteners to faster cognitive decline

Penn State team develops wearable sensor to track health through minimal sweat

Sugar-coated nanoparticles offer new hope for treating triple-negative breast cancer

Home-based hypertension care improves blood pressure control in rural South Africa

Novel ablation approach improves outcomes in patients with persistent atrial fibrillation

Changes at NIH give political appointees greater power to fund or block research

At CDC, worries mount that agency has taken anti-science turn

Roasted Arabica coffee hides powerful antidiabetic molecules

Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management

TRIMTECH Therapeutics establishes Scientific Advisory Board

Household WiFi devices show potential for nonintrusive health monitoring

Urine test identifies three biomarkers for accurate prostate cancer detection

Single-cell transcriptomics reveals new players in liver regeneration

Researchers reveal how diseases interact at the genetic level

Dormant tumor cells targeted to reduce breast cancer relapse

Nanostructures boost CRISPR delivery for genetic medicine

Social Security praises its new chatbot. Ex-officials say it was tested but shelved under Biden.

Aptamer signs therapeutic development agreement with Invizius

Compounds show significant inhibitory effects on α-glucosidase

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News